FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
022407NDATHERAVANCE INC001VIBATIVINJECTABLE; INJECTION250MGTELAVANCIN2013-06-21PrescriptionNo
002VIBATIVINJECTABLE; INJECTION750MGTELAVANCIN2013-06-21PrescriptionNo